This happened due to hepatic cell injury or death caused by lipotoxicity and hepatic inflammation in severe NAFLD or NASH patients so that the remaining hepatic cells were unable to produce as much FGF21 as needed (54, 76, 85). The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.